First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors

International Journal of Urology

Volumn 14, Issue 4, 2007, Pages 336-338

  Kumano, Masafumi ^a   Miyake, Hideaki ^a   Hara, Isao ^a   Furukawa, Junya ^a   Takenaka, Atsushi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Extragonadal germ cell tumor (EGGCT); High dose chemotherapy (HDCT); Induction chemotherapy; Peripheral blood stem cell transplantation (PBSCT)

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL;

ADOLESCENT; ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEVER; FOLLOW UP; GASTROINTESTINAL TOXICITY; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; TERATOMA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERITONEAL NEOPLASMS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34247573579     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01718.x     Document Type: Article

References (10)

1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N. Engl. J. Med. 1997 337 : 242 53.
2. Hainsworth CR, Greco FA. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin. Oncol. 1992 19 : 119 27.
3. Hartmann JT, Nichols CR, Droz JP et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J. Natl. Cancer Inst. 2000 92 : 54 61.
4. Bokemeryer C, Nichls CR, Droz JP et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J. Clin. Oncol. 2002 20 : 1864 73.
5. Schmoll HJ, Kollmannsberger C, Metzner B et al. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. J. Clin. Oncol. 2003 21 : 4083 91.
6. Hara I, Yamada Y, Miyake H et al. Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors. Anticancer Drug 1999 10 : 711 18.
7. Rosti G, De Giorgi U, Wandt H et al. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party. Bone Marrow Transplant. 2004 34 : 1033 7.
8. The Japanese Urological Association and The Japanese Pathological Society. General Rules for Clinical and Pathological Studies on Testicular Tumors. Kanehara, Tokyo, 1997.
9. Bokemeyer C, Kollmannsberger C, Meisner C et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis. J. Clin. Oncol. 1999 17 : 3450 6.
10. Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. J. Clin. Oncol. 1988 6 : 1031 40.